Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) ...

The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...

Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...

Inhaled corticosteroids (ICS) are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

As with asthma, people with COPD may experience coughing and shortness of breath. But morning coughing with phlegm is more characteristic of COPD. In contrast, asthma tends to cause worsening ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...

A remote monitoring program predicted when patients with asthma would experience distress, according to a poster presented at ...

Adults who had an above-average BMI, overweight or obesity during childhood have increased risk for developing chronic ...

The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...